Piramal Pharma receives SEBI's nod to list shares on stock exchange

Piramal Pharma (PPL) said it has received approval from the Securities and Exchange Board of India (SEBI) to list shares on domestic stock exchanges, BSE and NSE. The company said it expects its shares to be listed next week. Piramal Pharma has been demerged from Piramal Enterprises Ltd (PEL) as a part of the simplification of the corporate structure.